Knott David M Jr
13F Reported Value
ⓘ$168.0M
Holdings
85
Latest Filing
2026-03-31
Filing Quarter
Q1 2026
Portfolio Overview
Knott David M Jr disclosed 85 positions worth $168.0M in its Form 13F-HR for Q1 2026, led by $GOOGL (Alphabet Inc.) at 15.6% of the equity portfolio, followed by $APO and $SNDX. During the quarter the fund opened 9 new positions and exited 11 — including a new stake in $IOVA and a full exit from $CLMT. The portfolio is most concentrated in Healthcare (53.5% of disclosed assets). All figures are sourced directly from Knott David M Jr’s Form 13F-HR filing with the SEC under CIK 1892770.
AI Fund Analysis
Diversifying
$GOOG
$APO
$SNDX
$BBIO
$PTGX
$VRDN
$HELP
$OBIO
$ALKSSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q1 2026
Click any card to unlockTop Holdings
- 80.2#45
Quality
$26.2M91,420 sh - 55.7#1,145
Quality
$25.1M225,000 sh - 30.0#2,378
Quality
$9.9M422,000 sh - 31.7
Quality
$6.7M90,000 sh - 24.8
Quality
$6.6M63,000 sh - 45.5
Quality
$6.1M1,060,000 sh - 35.6
Quality
$5.7M19,477 sh - 30.6
Quality
$5.6M1,600,000 sh LPL Financial Holdings Inc.
—Quality
$5.0M16,500 shJanus Henderson AAA CLO ETF
—Quality
$4.7M93,528 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
 Alphabet Inc.$GOOGL | 80.2#45 | $26.2M | 91,420 |
| Apollo Global Management, Inc.$APO | 55.7#1,145 | $25.1M | 225,000 |
| Syndax Pharmaceuticals Inc$SNDX | 30.0#2,378 | $9.9M | 422,000 |
| BridgeBio Pharma, Inc.$BBIO | 31.7 | $6.7M | 90,000 |
| Protagonist Therapeutics, Inc$PTGX | 24.8 | $6.6M | 63,000 |
 Xeris Biopharma Holdings, Inc.$XERS | 45.5 | $6.1M | 1,060,000 |
 JPMORGAN CHASE & CO$JPM | 35.6 | $5.7M | 19,477 |
 IOVANCE BIOTHERAPEUTICS, INC.$IOVA | 30.6 | $5.6M | 1,600,000 |
| LPL Financial Holdings Inc. | — | $5.0M | 16,500 |
| Janus Henderson AAA CLO ETF | — | $4.7M | 93,528 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Knott David M Jr's 85 positions.
Showing top 10 of 85 holdings.
Sector Allocation
Healthcare
$90.0M
Financials
$32.7M
Technology
$28.1M
Other
$14.4M
Industrials
$1.0M
Energy
$853,394
Materials
$454,287
Consumer Staples
$273,874
Full Holdings — Knott David M Jr (Q1 2026)
All 85 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | $GOOGL | Alphabet Inc. | $26.2M | 15.6% | +0% | 80.2 |
| 2 | $APO | Apollo Global Management, Inc. | $25.1M | 14.9% | +0% | 55.7 |
| 3 | $SNDX | Syndax Pharmaceuticals Inc | $9.9M | 5.9% | +2% | 30 |
| 4 | $BBIO | BridgeBio Pharma, Inc. | $6.7M | 4.0% | +6% | 31.7 |
| 5 | $PTGX | Protagonist Therapeutics, Inc | $6.6M | 4.0% | -14% | 24.8 |
| 6 | $XERS | Xeris Biopharma Holdings, Inc. | $6.1M | 3.7% | +9% | 45.5 |
| 7 | $JPM | JPMORGAN CHASE & CO | $5.7M | 3.4% | +0% | 35.6 |
| 8 | $IOVA | IOVANCE BIOTHERAPEUTICS, INC. | $5.6M | 3.3% | NEW | 30.6 |
| 9 | — | LPL Financial Holdings Inc. | $5.0M | 3.0% | NEW | — |
| 10 | — | Janus Henderson AAA CLO ETF | $4.7M | 2.8% | +0% | — |
| 11 | $ALKS | Alkermes plc. | $4.2M | 2.5% | +26% | — |
| 12 |  $TVTX | Travere Therapeutics, Inc. | $4.2M | 2.5% | -24% | 39.2 |
| 13 |  $COGT | Cogent Biosciences, Inc. | $4.0M | 2.4% | +2% | — |
| 14 | $VRDN | Viridian Therapeutics, Inc.\DE | $3.5M | 2.1% | +25% | 30.5 |
| 15 |  $AGIO | AGIOS PHARMACEUTICALS, INC. | $3.1M | 1.9% | +417% | 26.3 |
| 16 |  $RLMD | RELMADA THERAPEUTICS, INC. | $3.1M | 1.8% | NEW | — |
| 17 |  $TGTX | TG THERAPEUTICS, INC. | $3.0M | 1.8% | +100% | 68.4 |
| 18 |  $CPRX | CATALYST PHARMACEUTICALS, INC. | $3.0M | 1.8% | -37% | 78.7 |
| 19 |  $ACLX | Arcellx, Inc. | $2.2M | 1.3% | -24% | 6.7 |
| 20 | — | SPDR S&P Biotech ETF | $1.9M | 1.1% | +15% | — |
| 21 |  $AB | ALLIANCEBERNSTEIN HOLDING L.P. | $1.8M | 1.1% | +0% | — |
| 22 |  $RCUS | Arcus Biosciences, Inc. | $1.8M | 1.0% | -33% | 12 |
| 23 |  $DCGO | DocGo Inc. | $1.7M | 1.0% | +0% | 24.6 |
| 24 | $HELP | CYBIN INC. | $1.7M | 1.0% | +23% | — |
| 25 |  $CYTK | CYTOKINETICS INC | $1.6M | 0.9% | -30% | 28 |
| 26 |  $CNTA | Centessa Pharmaceuticals plc | $1.5M | 0.9% | +875% | — |
| 27 |  $ATRC | AtriCure, Inc. | $1.5M | 0.9% | +0% | 47.6 |
| 28 |  $ARDX | ARDELYX, INC. | $1.2M | 0.7% | NEW | 35.3 |
| 29 | — | The Panagram BBB-B CLO ETF | $1.2M | 0.7% | +0% | — |
| 30 |  $JNJ | JOHNSON & JOHNSON | $1.2M | 0.7% | -29% | 72.8 |
| 31 |  $RZLT | Rezolute, Inc. | $1.1M | 0.7% | +9% | — |
| 32 | $OBIO | Orchestra BioMed Holdings, Inc. | $1.1M | 0.6% | +1% | 8.7 |
| 33 |  $MDGL | MADRIGAL PHARMACEUTICALS, INC. | $1.0M | 0.6% | +0% | 25.4 |
| 34 |  $VERA | Vera Therapeutics, Inc. | $1.0M | 0.6% | +0% | — |
| 35 |  $CNTB | Connect Biopharma Holdings Ltd | $1.0M | 0.6% | +94% | — |
| 36 | — | iShares Biotechnology ETF | $928,675 | 0.6% | +0% | — |
| 37 |  $PFE | PFIZER INC | $908,023 | 0.5% | +0% | 69 |
| 38 |  $BMY | BRISTOL MYERS SQUIBB CO | $826,174 | 0.5% | -38% | 70.1 |
| 39 |  $CNQ | CANADIAN NATURAL RESOURCES Ltd | $818,664 | 0.5% | +0% | — |
| 40 |  $BIIB | BIOGEN INC. | $733,320 | 0.4% | -33% | 65.6 |
| 41 |  $RARE | Ultragenyx Pharmaceutical Inc. | $692,796 | 0.4% | +65% | 31 |
| 42 |  $AAPL | Apple Inc. | $632,952 | 0.4% | +0% | 76.1 |
| 43 |  $MSFT | MICROSOFT CORP | $592,272 | 0.3% | +0% | 83.7 |
| 44 |  $VSTM | Verastem, Inc. | $551,200 | 0.3% | NEW | 40.8 |
| 45 |  $ADMA | ADMA BIOLOGICS, INC. | $542,402 | 0.3% | +0% | 76 |
| 46 |  $IBM | INTERNATIONAL BUSINESS MACHINES CORP | $519,285 | 0.3% | +0% | 66.7 |
| 47 | — | Biohaven Pharmaceutical Holding Co. Ltd | $513,691 | 0.3% | NEW | — |
| 48 |  $PTHS | Pelthos Therapeutics Inc. | $442,744 | 0.3% | +9% | 25.4 |
| 49 |  $KURA | Kura Oncology, Inc. | $428,996 | 0.3% | +35% | 9.1 |
| 50 |  $EOLS | Evolus, Inc. | $408,279 | 0.2% | +0% | 30 |
| 51 |  $CGEM | Cullinan Therapeutics, Inc. | $343,882 | 0.2% | NEW | — |
| 52 |  $SLDB | Solid Biosciences Inc. | $339,430 | 0.2% | -71% | — |
| 53 |  $LENZ | LENZ Therapeutics, Inc. | $308,648 | 0.2% | -37% | 19.6 |
| 54 |  $WVE | Wave Life Sciences Ltd. | $290,000 | 0.2% | -56% | — |
| 55 |  $RAIN | Rain Enhancement Technologies Holdco, Inc. | $258,282 | 0.1% | NEW | — |
| 56 |  $KMB | KIMBERLY CLARK CORP | $231,528 | 0.1% | +0% | 61.7 |
| 57 |  $NVDA | NVIDIA CORP | $223,290 | 0.1% | +0% | 90.2 |
| 58 |  $RHP | Ryman Hospitality Properties, Inc. | $221,448 | 0.1% | +0% | 64.8 |
| 59 |  $AVGO | Broadcom Inc. | $219,859 | 0.1% | +0% | 86.4 |
| 60 |  $MDLZ | Mondelez International, Inc. | $172,920 | 0.1% | +0% | 53.9 |
| 61 |  $DD | DuPont de Nemours, Inc. | $172,529 | 0.1% | +0% | 31.1 |
| 62 |  $JSPR | Jasper Therapeutics, Inc. | $140,883 | 0.1% | -11% | — |
| 63 |  $IVVD | Invivyd, Inc. | $130,000 | 0.1% | +0% | 25.7 |
| 64 |  $CTVA | Corteva, Inc. | $100,954 | 0.1% | +0% | 48.4 |
| 65 |  $MREO | Mereo BioPharma Group plc | $99,111 | 0.1% | +0% | — |
| 66 |  $EBC | Eastern Bankshares, Inc. | $97,800 | 0.1% | +0% | 62.3 |
| 67 |  $PWR | QUANTA SERVICES, INC. | $96,628 | 0.1% | +0% | 62.6 |
| 68 | — | iShares Russell Mid-Cap Growth | $89,043 | 0.1% | +0% | — |
| 69 | $GOOG | Alphabet Inc. | $86,268 | 0.1% | +0% | 80.2 |
| 70 |  $LEGH | Legacy Housing Corp | $81,720 | 0.1% | +0% | 52.8 |
| 71 |  $AMZN | AMAZON COM INC | $62,493 | 0.0% | +0% | 74.6 |
| 72 |  $URI | UNITED RENTALS, INC. | $56,828 | 0.0% | +0% | 70.7 |
| 73 |  $DOW | DOW INC. | $50,230 | 0.0% | +0% | 38 |
| 74 |  $OXY | OCCIDENTAL PETROLEUM CORP /DE/ | $34,730 | 0.0% | +0% | 66.3 |
| 75 |  $DHR | DANAHER CORP /DE/ | $34,128 | 0.0% | +0% | 63.9 |
| 76 |  $BRSL | Brightstar Lottery PLC | $31,850 | 0.0% | NEW | — |
| 77 |  $FSK | FS KKR Capital Corp | $29,267 | 0.0% | +0% | — |
| 78 |  $BX | Blackstone Inc. | $24,148 | 0.0% | +0% | 68 |
| 79 |  $TMO | THERMO FISHER SCIENTIFIC INC. | $22,119 | 0.0% | +0% | 63.7 |
| 80 |  $UNH | UNITEDHEALTH GROUP INC | $15,424 | 0.0% | +0% | 66.8 |
| 81 |  $CRM | Salesforce, Inc. | $14,374 | 0.0% | +0% | 75.2 |
| 82 |  $STWD | STARWOOD PROPERTY TRUST, INC. | $6,888 | 0.0% | +0% | 54.6 |
| 83 |  $KD | Kyndryl Holdings, Inc. | $5,615 | 0.0% | +0% | 46 |
| 84 |  $GEHC | GE HealthCare Technologies Inc. | $3,559 | 0.0% | +0% | 58.2 |
| 85 |  $WAB | WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP | $1,499 | 0.0% | +0% | 70.8 |
New Positions (9)
$IOVA IOVANCE BIOTHERAPEUTICS, INC.$5.6M$RLMD RELMADA THERAPEUTICS, INC.$3.1M$ARDX ARDELYX, INC.$1.2M$VSTM Verastem, Inc.$551,200$CGEM Cullinan Therapeutics, Inc.$343,882$RAIN Rain Enhancement Technologies Holdco, Inc.$258,282$BRSL Brightstar Lottery PLC$31,850Exited Positions (11)
$CLMT Calumet, Inc. /DE
$TECX Tectonic Therapeutic, Inc.
$BHVN Biohaven Ltd.
$NKTR NEKTAR THERAPEUTICS
$SRRK Scholar Rock Holding Corp
$XENE Xenon Pharmaceuticals Inc.
$FATE FATE THERAPEUTICS INC
$DAWN Day One Biopharmaceuticals, Inc.
$QURE uniQure N.V.Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Knott David M Jr including:
Track Knott David M Jr's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Knott David M Jr and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Knott David M Jr
13F Pro is an AI hedge fund tracker and stock research platform. For Knott David M Jr (SEC CIK: 1892770), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Knott David M Jr's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.